Read about Recursive’s Flint AI coding model, its laptop-friendly design, coding benchmarks, open-source license, and Eureka ...

Recursive released its first model, Flint, on Wednesday. The startup, founded last year, says AI provided much of the assistance used to develop the free laptop ...

Startup Recursive has released Flint, a free, laptop-sized coding model built largely by its own AI research system, as an early test of AI that improves itself.

KYOTO, JAPAN — At the 23rd Annual Meeting of the Science and Technology in Society (STS) Forum convened in Kyoto, the United States and 16 countries endorsed the Kyoto Vision for a Golden Age of ...

In the high-tech, high-competition AI field, we are seeing new versions of models rolled out by the frontier companies (OpenAI, Google and Anthropic) every month and a half. I included a Release ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today announced an extension of its data license agreement with Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX). Additionally, the two companies ...

“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...

Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

The up-to-$12 billion artificial intelligence (AI) drug discovery collaboration of Recursion, Roche, and its Genentech subsidiary marked a milestone Wednesday when plans were announced for Recursion ...